Debts
€950,452 98% of the balance sheet
Financial debts 94%Suppliers 0%Other 6%
Of this, €53,712 falls due within a year.
MEDIFICE
Lifetime
5 annual accounts with figures on one time axispeak €94,403 (2025)
€94,403▲ 129%
lowest -€32,217 (2021)
€29,898▲ 24×
peak €15,115 (2025)
€15,115▲ €29,898
€950,452▼ 10.5%
Board5 names since 2020
3 directors and 2 others
Documentsfilings and deeds
28-08-202628 days late
2025micro format
Gross margin from €41,301 to €94,403Result from €1,249 to €29,898Appointment: (director) 30-10Equity from -€14,783 to €15,115
Key points
from the 2025 annual accountsSecurities
€740,000
Mortgage mandates, new in 2025. 49.0 times equity · not in the 2024 accounts.
Filings
5 annual accounts 3 late
The 2022 accounts came latest: 30 days after the end of the period.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 1,603 companies had the same profile as MEDIFICE has now. Each dot stands for 5 companies, two years later.
95.9%
were still trading
1.8%
stopped another way
1.9%
went bankrupt
Another 0.4% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,603 companies, not a prediction for MEDIFICE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 23-10-2020
Director, since 23-10-2020
Director, since 07-07-2025
- founderdeed of 03-11-2020
- founderdeed of 03-11-2020
- founderdeed of 03-11-2020
Recent changes
Appointment: (director)
General meeting of 23-07-2025 · Gazette deed
Resignation: (director)
Transfer of shares from · General meeting of 13-07-2021 · Gazette deed
Incorporation
Founders: , and · 120 shares · Appointments: , and · published on 03-11-2020 · Gazette deed
First establishment
Rue du Dessus 60, Chastre
Official details
Source: KBO- Status
- Active since 29-10-2020Normal situation
- Activity
- “La constitution,le développement,la promotion et la gestion d’un patrimoine immobilier” (deed in French)From the articles, 5 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.321.959.8681450 Chastre, since 29-10-2020
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Insights on MEDIFICE
MEDIFICE files the micro format. That format states no turnover. The gross margin rose from -€4,944 in 2021 to €94,403 in 2025.
The balance sheet grew most from 2022 to 2024 through fixed assets, financed with long-term debt.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about MEDIFICE
- What is the company number of MEDIFICE?
- The company number of MEDIFICE is 0757.632.950. The VAT number is the same number with BE in front: BE 0757.632.950.
- Where is MEDIFICE based?
- The registered office is at Rue du Dessus 60, 1450 Chastre.Company details
- What is the legal form of MEDIFICE?
- MEDIFICE is a private limited company (BV).
- When was MEDIFICE founded?
- MEDIFICE was founded on 29-10-2020.
- Is MEDIFICE still active?
- Yes, MEDIFICE is an active enterprise in the KBO register.
- What is the turnover of MEDIFICE?
- The turnover in financial year 2025 is ≈ €280,000. This figure is estimated from the gross margin of €94,403 and 2,982 comparable companies of the same size. It probably lies between €180,000 and €490,000. It is a rough estimate.Financials
- Is MEDIFICE profitable?
- In financial year 2025, MEDIFICE made a profit of €29,898.
- Where can I find the annual accounts of MEDIFICE?
- MEDIFICE filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of MEDIFICE due?
- MEDIFICE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.